![Inflazome](http://uatcdn.smartcompany.com.au/wp-content/uploads/2018/12/Matt-Inflazome-WEB.jpg?w=306&h=148&crop=1)
Queensland biotech startup Inflazome raises $63 million to change the way we treat Alzheimer’s
Biotech startup Inflazome has raised $63 million to commercialise its drug slowing the progress of inflammatory diseases like Alzheimer’s and Parkinson’s.